| Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis J Bourhis, J Overgaard, H Audry, KK Ang, M Saunders, J Bernier, ... The Lancet 368 (9538), 843-854, 2006 | 1377* | 2006 |
| Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 … JB Vermorken, J Stöhlmacher-Williams, I Davidenko, L Licitra, E Winquist, ... The lancet oncology 14 (8), 697-710, 2013 | 494 | 2013 |
| Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis B Lacas, J Bourhis, J Overgaard, Q Zhang, V Grégoire, M Nankivell, ... The Lancet Oncology 18 (9), 1221-1237, 2017 | 332 | 2017 |
| Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study QT Le, HE Kim, CJ Schneider, G Muraközy, K Skladowski, S Reinisch, ... J Clin Oncol 29 (20), 2808-2814, 2011 | 235 | 2011 |
| Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer–report on 3-year tumour control and normal tissue toxicity K Skladowski, B Maciejewski, M Golen, B Pilecki, W Przeorek, ... Radiotherapy and Oncology 55 (2), 101-110, 2000 | 224 | 2000 |
| Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised … J Giralt, J Trigo, S Nuyts, M Ozsahin, K Skladowski, G Hatoum, JF Daisne, ... The Lancet Oncology 16 (2), 221-232, 2015 | 182 | 2015 |
| Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled … R Mesía, M Henke, A Fortin, H Minn, ACY Ancona, A Cmelak, ... The Lancet Oncology 16 (2), 208-220, 2015 | 177 | 2015 |
| Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity B Maciejewski, K Skladowski, B Pilecki, JMG Taylor, RH Withers, ... Radiotherapy and oncology 40 (2), 137-145, 1996 | 163 | 1996 |
| Hyperfractionated or accelerated radiotherapy for head and neck cancer B Baujat, J Bourhis, P Blanchard, J Overgaard, KK Ang, M Saunders, ... Cochrane Database of Systematic Reviews, 2010 | 147 | 2010 |
| How fast is repopulation of tumor cells during the treatment gap? R Tarnawski, J Fowler, K Skladowski, A Świerniak, R Suwiński, ... International Journal of Radiation Oncology* Biology* Physics 54 (1), 229-236, 2002 | 145 | 2002 |
| Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx R Tarnawski, K Skladowski, B Maciejewski International Journal of Radiation Oncology* Biology* Physics 38 (5), 1007-1011, 1997 | 118 | 1997 |
| Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration K Skladowski, MG Law, B Maciejewski, GG Steel Radiotherapy and Oncology 30 (2), 109-120, 1994 | 114 | 1994 |
| Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer B Maciejewski, A Zajusz, B Pilecki, J Swiatnicka, K Skladowski, W Dorr, ... Radiotherapy and oncology 22 (1), 7-11, 1991 | 106 | 1991 |
| Clinical radiobiology of glottic T1 squamous cell carcinoma K Skladowski, R Tarnawski, B Maciejewski, A Wygoda, K Slosarek International Journal of Radiation Oncology* Biology* Physics 43 (1), 101-106, 1999 | 96 | 1999 |
| Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial K Skladowski, B Maciejewski, M Golen, R Tarnawski, K Slosarek, ... International Journal of Radiation Oncology* Biology* Physics 66 (3), 706-713, 2006 | 87 | 2006 |
| Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis C Petit, B Lacas, JP Pignon, QT Le, V Grégoire, C Grau, A Hackshaw, ... The Lancet Oncology 22 (5), 727-736, 2021 | 57 | 2021 |
| The role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and platelets in the prognosis of metastatic renal cell carcinoma J Huszno, Z Kolosza, J Mrochem-Kwarciak, T Rutkowski, K Skladowski Oncology 97 (1), 7-17, 2019 | 48 | 2019 |
| Primary efficacy and safety results of SPECTRUM, a phase 3 trial in patients (pts) with recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN … JB Vermorken, J Stöhlmacher, I Davidenko, L Licitra, E Winquist, ... Annals of Oncology 21, 12-12, 2010 | 41 | 2010 |
| Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation A Wygoda, B Maciejewski, K Skladowski, M Hutnik, B Pilecki, M Golen, ... International Journal of Radiation Oncology* Biology* Physics 73 (2), 384-390, 2009 | 40 | 2009 |
| Radiation-induced changes in serum lipidome of head and neck cancer patients K Jelonek, M Pietrowska, M Ros, A Zagdanski, A Suchwalko, J Polanska, ... International journal of molecular sciences 15 (4), 6609-6624, 2014 | 35 | 2014 |
Rafal SuwinskiProfessor, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice BranchVerified email at io.gliwice.pl
